Sage's essential tremor drug fails in another blow to pipeline, Biogen partnership
Sage and its partner Biogen said their experimental oral medicine failed a Phase 2 test in essential tremor and they will …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
